doi: 10.1039/C5CS00165J 225
PMC 2813020
In a randomized clinical trial involving pediatric patients with attention deficit hyperactivity disorder, PYC treatment produced a modest increase in catalase activity, suggesting potential antioxidant effects (Weyns et al., 2022)
Extended Half-Life: CJC-1295 has a longer duration of action, allowing sustained benefits
In APP/PS1 Alzheimer's mice, Dihexa treatment not only prevented cognitive decline but actively restored spatial learning abilities that had already been compromised, indicating the compound promotes recovery of function in damaged neural circuits
Cancer Res 64 : 236242 Girnita L, Girnita A, Brodin B, Xie Y, Nilsson G, Dricu A, Lundeberg J, Wejde J, Bartolazzi A, Wiman KG, Larsson O (2000) Increased expression of insulin-like growth factor I receptor in malignant cells expressing aberrant p53: functional impact